Search
for
Sort by
Research 481–510 of 1000+
- [G-proteins, receptor signal transduction, and growth hormone secretion].
- Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
- Study of Cutaneous Manifestations of Polycystic Ovarian Syndrome
- Pharmacology and Potential Use of Cyproterone Acetate
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- The Treatment of Hyperandrogenism with Oral Contraceptives
- Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ)
- The dermatologic manifestation of hyperandrogenism: A retrospective chart review
- PCOS: Perspectives from a Pediatric Endocrinologist and a Pediatric Gynecologist
- The use of testosterone after menopause
- Markers of peripheral androgen action in vivo and in vitro
- A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students
- Study of cutaneous manifestations of polycystic ovarian syndrome
- A Review on Health Care Surveillance of PCOD
- Correlation of Cutaneous Manifestations With Body Mass Index (BMI) in Polycystic Ovary Syndrome (PCOS) Patients in a Tertiary Care Centre: An Observational Study
- 466 Clinical technique and outcomes of platelet-rich plasma application for treatment of androgenic and scarring alopecia, acne scarring, melasma, and facial rejuvenation: A prospective multicenter study
- Modern approach to the treatment of patients with androgen-dependent dermatopathies
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- The Assessment of Appearance Factors Related to Intentional UV Exposure
- The treatment of polycystic ovary syndrome and systematization of knowledge - literature review
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- POLYCYSTIC OVARIAN SYNDROME;
- [Anti-androgens. Their use in dermatology].
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- The association of cytosine-adenine-guanine repeat polymorphism in the androgen receptor gene with nodulocystic acne in Egyptian patients
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- Topical Antiandrogens
- Reduction of oral tetracycline of lipolysis of triglycerides in hair lipid